ng-nitroarginine methyl ester has been researched along with Morbid Obesity in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Bruno, RM; Cappelli, F; Duranti, E; Mengozzi, A; Moriconi, D; Nannipieri, M; Taddei, S; Virdis, A | 1 |
Abraham, D; Al-Jaber, M; Bakhamis, A; Bashah, M; Clapp, LH; Mohamed-Ali, V; Orie, NN; Raees, A | 1 |
Anselmino, M; Chiarugi, M; Dell'Agnello, U; Duranti, E; Rossi, C; Santini, E; Solini, A; Taddei, S; Virdis, A | 1 |
3 other study(ies) available for ng-nitroarginine methyl ester and Morbid Obesity
Article | Year |
---|---|
The renal resistive index is associated with microvascular remodeling in patients with severe obesity.
Topics: Albuminuria; Humans; Hypertension; Kidney; Microcirculation; NG-Nitroarginine Methyl Ester; Obesity; Obesity, Morbid; Vascular Resistance | 2023 |
Altered cyclooxygenase-1 and enhanced thromboxane receptor activities underlie attenuated endothelial dilatory capacity of omental arteries in obesity.
Topics: Adipose Tissue; Adult; Apamin; Arteries; Celecoxib; Charybdotoxin; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Endothelial Cells; Endothelium, Vascular; Female; Gastroepiploic Artery; Humans; Indomethacin; Male; Middle Aged; Muscle Relaxation; NG-Nitroarginine Methyl Ester; Obesity, Morbid; Omentum; Receptors, Thromboxane; Vasodilation | 2019 |
Tumour necrosis factor-alpha participates on the endothelin-1/nitric oxide imbalance in small arteries from obese patients: role of perivascular adipose tissue.
Topics: Case-Control Studies; Cells, Cultured; Endothelin A Receptor Antagonists; Endothelin Receptor Antagonists; Endothelin-1; Enzyme Inhibitors; Female; Humans; Infliximab; Intra-Abdominal Fat; Male; Microvessels; Middle Aged; NG-Nitroarginine Methyl Ester; Nitric Oxide; Obesity, Morbid; Peptides, Cyclic; Receptor, Endothelin A; Receptors, Tumor Necrosis Factor; Superoxides; Tumor Necrosis Factor-alpha; Vasoconstriction | 2015 |